- Home
- / Chongqing Lummy Pharmaceutical
Chongqing Lummy Pharmaceutical
Stock Price
¥4.1
2024-10-29
Market Capitalization
¥4.2 B
2024-10-29
Revenue
¥748.2 M
FY, 2025
Chongqing Lummy Pharmaceutical Summary
Company Summary
- Overview
- Chongqing Lummy Pharmaceutical is a manufacturing company. It offers anti-tumor, digestive, blood system, antifungal, and antibacterial tablet products. The company caters to the pharmaceutical, and drugs sectors.
- Type
- Public
- Status
- Active
- Founded
- 1999
- Website
- http://cqlummy.com
- Cybersecurity rating
Table of Contents
Chongqing Lummy Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥178.8M
- Gross profit (Q1, 2026)
- ¥96.8M
- Net income (Q1, 2026)
- (¥13.6M)
- Cash (Q1, 2026)
- ¥919.7M
- EBIT (Q1, 2026)
- (¥5.5M)
- Enterprise value
- $3.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026